SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer
University of Washington
University of Washington
Fred Hutchinson Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
Alliance for Clinical Trials in Oncology
Thomas Jefferson University
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
Mayo Clinic
Emory University
Thomas Jefferson University
University of Washington
NRG Oncology
NRG Oncology
NRG Oncology
University of Rochester
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
University of Washington
City of Hope Medical Center
University of Washington
City of Hope Medical Center
Mayo Clinic
University of Michigan Rogel Cancer Center
Northwestern University
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
City of Hope Medical Center
NRG Oncology
Vanderbilt-Ingram Cancer Center
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
IRCCS San Raffaele
City of Hope Medical Center
Emory University
Vanderbilt-Ingram Cancer Center
Roswell Park Cancer Institute
University of Southern California
Assistance Publique - Hôpitaux de Paris
Emory University
University of Washington
Northwestern University
Vanderbilt-Ingram Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
University of Wisconsin, Madison
The Christie NHS Foundation Trust